Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for antigen targeting to CD180

Compositions and methods for antigen targeting to CD180

US Patent 12018291 · Granted Jun 25, 2024

Estimated economic value: $937,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen2025
Compositions and methods for antigen targeting to CD1802025
Compositions and methods for antigen targeting to CD1802025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Compositions and methods for antigen targeting to CD1802023
Compositions and methods for antigen targeting to CD1802023
Temperature based plasmid regulation system2022
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS22022
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen2022
Tolerogenic DNA vaccine2022
Compositions and methods for antigen targeting to CD1802020